| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P819 | ADS bibcode | 2014PLoSO...994376H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0094376 |
| P932 | PMC publication ID | 4020764 |
| P698 | PubMed publication ID | 24827118 |
| P5875 | ResearchGate publication ID | 262338876 |
| P2093 | author name string | Yong Zhang | |
| Peng Wang | |||
| Yong Huang | |||
| Zhi Du | |||
| Fengmei Wang | |||
| Yingtang Gao | |||
| Rongfa Yuan | |||
| Huaiwei Liao | |||
| P2860 | cites work | Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis | Q27004677 |
| Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis | Q27024810 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas | Q31081979 | ||
| Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-β1 in gastric cancer | Q31118578 | ||
| Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia | Q33500351 | ||
| Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma | Q33865610 | ||
| Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis | Q34026203 | ||
| Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review | Q34551974 | ||
| Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer | Q34575227 | ||
| The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature | Q34637571 | ||
| Prognostic value of Ezrin in solid tumors: a meta-analysis of the literature | Q34872783 | ||
| Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity | Q34984596 | ||
| Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma | Q35049963 | ||
| Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration | Q36344582 | ||
| Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer | Q36608731 | ||
| FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer | Q36695079 | ||
| Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. | Q36787548 | ||
| CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer | Q37149721 | ||
| The significance of Treg cells in defective tumor immunity | Q37177121 | ||
| High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment | Q37650692 | ||
| Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer | Q37885285 | ||
| Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach | Q39351950 | ||
| Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells | Q39564214 | ||
| Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer | Q42954285 | ||
| Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells | Q43856649 | ||
| Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer | Q44900324 | ||
| IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. | Q46885750 | ||
| Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma | Q46957020 | ||
| Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. | Q50960953 | ||
| Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. | Q53245555 | ||
| Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. | Q53332082 | ||
| FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. | Q53572147 | ||
| Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer | Q56101218 | ||
| Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer | Q56932821 | ||
| Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers | Q61865594 | ||
| Regulatory T cells and the liver: a new piece of the puzzle | Q81571723 | ||
| CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer | Q82504535 | ||
| Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma | Q82684267 | ||
| [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma] | Q82868280 | ||
| Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer | Q83176803 | ||
| Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection | Q83469111 | ||
| Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection | Q83701996 | ||
| Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma | Q83932844 | ||
| Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients | Q84151112 | ||
| [Expression and prognostic value of M2 macrophages and regulatory T cells in gastric carcinoma tissue] | Q84199554 | ||
| Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection | Q84373285 | ||
| Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1 | Q84418006 | ||
| The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer | Q84598304 | ||
| High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients | Q84782027 | ||
| Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer | Q84889571 | ||
| Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients | Q85599721 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | e94376 | |
| P577 | publication date | 2014-05-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis | |
| P478 | volume | 9 |
| Q57805095 | Q57805095 |
| Q57805108 | Q57805108 |
| Q37619675 | Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers |
| Q89444385 | Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer |
| Q36299762 | Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer |
| Q33889323 | Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis |
| Q26779184 | Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy |
| Q34142307 | FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis |
| Q41431266 | HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer |
| Q92645821 | Immunohistochemical distribution of FOXP3+ regulatory T cells in colorectal cancer patients |
| Q39965259 | Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy |
| Q93134021 | Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer |
| Q89613150 | Janus or Hydra: The Many Faces of T Helper Cells in the Human Tumour Microenvironment |
| Q47372761 | Liquid biopsies in gastrointestinal malignancies: when is the big day? |
| Q53200151 | Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy. |
| Q92879135 | Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression |
| Q92073923 | Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence |
| Q64054511 | Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis |
| Q98466821 | Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients |
| Q60955504 | Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis |
| Q64268017 | Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis |
| Q47134263 | Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma |
| Q94571886 | Reduction of FoxP3+ Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma |
| Q47101966 | The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis |
| Q89882588 | The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis |
| Q38633171 | The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis |
| Q60917471 | The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis |
| Q38691172 | The immune system and cancer evasion strategies: therapeutic concepts |
| Q87685386 | Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study |
| Q46479553 | Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis |
| Q41763532 | Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis |
| Q56895579 | Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer |
Search more.